Nu Skin Enterprises Reports First Quarter Financial Results

Company News

Printer Friendly Version View printer-friendly version << Back
May 4, 2022 at 4:06 PM EDT

Nu Skin Enterprises Reports First Quarter Financial Results

PROVO, Utah, May 4, 2022 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced first quarter 2022 results.

Executive Summary
Q1 2022 vs. Prior-year Quarter

Revenue:

$604.9 million; (11)%

  • (3)% FX impact or $(17.2) million

Earnings Per Share (EPS):

$0.76; (16)%

Customers:

1,321,451; (13)%

Paid Affiliates:

251,436; (14)%

Sales Leaders:

52,462; (22)%

 

"Despite heightened global uncertainty and COVID-related obstacles, we are pleased with our first quarter results, which exceeded guidance," said Ryan Napierski, Nu Skin president and CEO. "Demand remained strong for our most recent product introductions, ageLOC® Meta and Beauty Focus™ Collagen+, and the momentum from these product launches helped drive strong revenue growth in several markets including the U.S., Taiwan and Southeast Asia. Our business in Mainland China and several other markets was disrupted due to severe COVID-related lockdowns and other factors, and the conflict in Ukraine and Russia negatively impacted business throughout the EMEA region.

"As we look ahead to the remainder of the year, we are focused on the strategic imperatives that underpin Nu Vision 2025, including: EmpowerMe, our personalized beauty and wellness strategy with connected beauty device introductions beginning in the third quarter; expansion of our affiliate-powered social commerce business model; and the continued enhancement of our digital platform. While we anticipate near-term headwinds given the dynamic macro environment, we remain confident in the significant growth potential of our business, achieving our vision for the future and driving value for our shareholders."

Q1 2022 Year-over-year Operating Results                

Revenue:

$604.9 million compared to $677.0 million

  • (3)% FX impact

Gross Margin:

73.3% compared to 74.8%

  • Impacted by product mix and promotions
  • Nu Skin business was 76.5% compared to 77.8%

Selling Expenses:

40.1% compared to 40.8%

  • Nu Skin business was 43.0% compared to 43.7%

G&A Expenses:

24.6% compared to 24.8%

Operating Margin:

8.6% compared to 9.3%

Other Income / (Expense):

$(1.5) million compared to $1.6 million

Income Tax Rate:

23.6% compared to 26.5%

EPS:

$0.76 compared to $0.91

 

Stockholder Value

Dividend Payments:

$19.3 million

Stock Repurchases:

$10.0 million

  • $235.4 million remaining in authorization

 

Q2 and Full-year 2022 Outlook

Q2 2022 Revenue:

$590 to $620 million; (16) to (12)%

  • Approximately (3) to (4)% FX impact

Q2 2022 EPS:

$0.75 to $0.85; (35) to (26)%

2022 Revenue:

$2.51 to $2.62 billion; (7) to (3)%

  • Approximately (3) to (4)% FX impact

2022 EPS:

$3.60 to $3.90; 26 to 36% on a reported basis, or (13) to (6)% non-GAAP

 

"Our results outperformed expectations in the first quarter including a beat in revenue and earnings per share driven in part by sales late in the quarter ahead of an April 1 price increase," added Mark Lawrence, chief financial officer. "In light of the ongoing global uncertainties, including increasing COVID-related factors, foreign exchange pressure and geopolitical conflict, we are adjusting our annual guidance. Our 2022 revenue guidance is $2.51 to $2.62 billion with a 3 to 4 percent foreign currency headwind and EPS of $3.60 to $3.90. We are projecting second quarter revenue of $590 to $620 million with a 3 to 4 percent foreign currency headwind and EPS of $0.75 to $0.85."

Conference Call
The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company's website at ir.nuskin.com. A replay of the webcast will be available on the same page through May 18, 2022.

About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NYSE: NUS) is a leading beauty and wellness company, powered by a dynamic affiliate opportunity platform. The company helps people look, feel and live their best with products that combine the best of science, technology and nature. Backed by more than 35 years of scientific research, Nu Skin develops innovative products including Nu Skin® personal care, Pharmanex® nutrition and the ageLOC® anti-aging brand which includes an award-winning line of beauty device systems. Nu Skin operates in approximately 50 markets worldwide in the Americas, Asia, Europe, Africa and the Pacific. Rhyz Inc. is the company's strategic investment arm that includes a collection of technology and manufacturing companies to support growth in the core Nu Skin business. Nu Skin is committed to sustainability, including global initiatives such as transitioning to reduced and sustainable packaging for all products by 2030. The Nu Skin Force for Good Foundation also strives to improve children's health, education and economic circumstances throughout the world. For more information, visit nuskin.com.

Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, growth, shareholder value, strategies, vision, transformation, initiatives, product pipeline and product introductions, digital and social-commerce tools and initiatives, customers, sales leaders and affiliates; operational improvements, projections regarding revenue, expenses, operating income, earnings per share, foreign currency fluctuations, uses of cash and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "anticipate," "project," "outlook," "guidance," "remain," "become," "plan," "opportunity," "expand," "will," "would," "could," "may," "might," the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

  • risk that epidemics, including the ongoing COVID-19 pandemic, and other crises could negatively impact our business;
  • adverse publicity related to the company's business, products, industry or any legal actions or complaints by the company's sales force or others;
  • risk that direct selling laws and regulations in any of the company's markets, including the United States and Mainland China, may be modified, interpreted or enforced in a manner that results in negative changes to the company's business model or negatively impacts its revenue, sales force or business, including through the interruption of sales activities, loss of licenses, increased scrutiny of sales force actions, imposition of fines, or any other adverse actions or events;
  • any failure of current or planned initiatives or products to generate interest among the company's sales force and customers and generate sponsoring and selling activities on a sustained basis;
  • political, legal, tax and regulatory uncertainties associated with operating in international markets, including Mainland China;
  • uncertainty regarding meeting restrictions and other government scrutiny in Mainland China, as well as negative media and consumer sentiment in Mainland China on our business operations and results;
  • risk of foreign-currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;
  • uncertainties regarding the future financial performance of the businesses the company has acquired;
  • risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support planned initiatives or launch strategies, and increased risk of inventory write-offs if the company over-forecasts demand for a product or changes its planned initiatives or launch strategies;
  • regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit its ability to import or continue selling a product in a market if the product is determined to be a medical device or if the company is unable to register the product in a timely manner under applicable regulatory requirements;
  • unpredictable economic conditions and events globally, including trade policies and tariffs;
  • the company's future tax-planning initiatives; any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States; and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and
  • continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

Non-GAAP Financial Measures: Constant-currency revenue change is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company's performance. It is calculated by translating the current period's revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period's revenue. The company believes that constant-currency revenue change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company's revenue from period to period.

Earnings per share and adjusted earnings per share growth, each excluding impairment and restructuring charges, also are non-GAAP financial measures. Impairment and restructuring charges are not part of the ongoing operations of our underlying business. The company believes that these non-GAAP financial measures are useful to investors, lenders and analysts because removing the impact of impairment and restructuring charges facilitates period-to-period comparisons of the company's performance. Please see the reconciliations of these items to our earnings per share and earnings per share growth calculated under GAAP, below.

The following table sets forth revenue for the three-month periods ended March 31, 2022 and 2021 for each of our reportable segments (U.S. dollars in thousands):


Three Months Ended

March 31,




Constant-
Currency


2022


2021


Change  


Change

Nu Skin












          Mainland China

$

124,495


$

149,593



(17)%



(18)%

          Americas


123,580



133,761



(8)%



(6)%

          Southeast Asia/Pacific


90,236



83,289



8%



11%

          South Korea


72,133



81,131



(11)%



(4)%

          Japan


61,791



69,864



(12)%



(3)%

          EMEA


52,968



76,180



(30)%



(25)%

          Hong Kong/Taiwan


38,494



36,345



6%



6%

          Other


620



878



(29)%



(29)%

Total Nu Skin


564,317



631,041



(11)%



(8)%

Rhyz Investments












          Manufacturing


40,341



45,985



(12)%



(12)%

          Rhyz other


241









Total Rhyz Investments


40,582



45,985



(12)%



(12)%

     Total

$

604,899


$

677,026



(11)%



(8)%

 

The following table provides information concerning the number of Customers, Paid Affiliates and Sales Leaders in our core Nu Skin business for the three-month periods ended March 31, 2022 and 2021:


Three Months Ended

March 31,



Customers

2022


2021


Change  

     Mainland China


289,060



316,000


(9)%

     Americas


318,458



374,867


(15)%

     Southeast Asia/Pacific


165,657



185,435


(11)%

     South Korea


140,648



152,390


(8)%

     Japan


122,616



126,525


(3)%

     EMEA


216,037



296,001


(27)%

     Hong Kong/Taiwan


68,975



66,042


4%

Total 


1,321,451



1,517,260


(13)%

 

 


Three Months Ended

March 31,



Paid Affiliates

2022


2021


Change  

     Mainland China


22,762



41,944


(46)%

     Americas


46,281



52,767


(12)%

     Southeast Asia/Pacific


43,262



45,871


(6)%

     South Korea


49,328



51,006


(3)%

     Japan


38,059



38,283


(1)%

     EMEA


33,834



43,696


(23)%

     Hong Kong/Taiwan


17,910



17,885


Total 


251,436



291,452


(14)%

 

 


Three Months Ended

March 31,



Sales Leaders

2022


2021


Change  

     Mainland China


14,146



23,013


(39)%

     Americas


9,547



11,394


(16)%

     Southeast Asia/Pacific


8,012



8,446


(5)%

     South Korea


6,072



6,682


(9)%

     Japan


5,977



6,135


(3)%

     EMEA


5,455



7,479


(27)%

     Hong Kong/Taiwan


3,253



3,755


(13)%

Total 


52,462



66,904


(22)%

 

"Customers" are persons who have purchased directly from the Company during the three months ended as of the date indicated. Our Customer numbers include members of our sales force who made such a purchase, including Paid Affiliates and those who qualify as Sales Leaders, but they do not include consumers who purchase products directly from members of our sales force.

"Paid Affiliates" are any Brand Affiliates, as well as sales employees and independent marketers in Mainland China, who earned sales compensation during the three-month period. In all of our markets besides Mainland China, we refer to members of our independent sales force as "Brand Affiliates" because their primary role is to promote our brand and products through their personal social networks.

"Sales Leaders" are the three-month average of our monthly Brand Affiliates, as well as sales employees and independent marketers in Mainland China, who had achieved certain qualification requirements as of the end of each month of the quarter.

NU SKIN ENTERPRISES, INC.


Consolidated Statements of Income (Unaudited)


(U.S. dollars in thousands, except per share amounts)





Three Months Ended

March 31,


2022


2021







Revenue

$

604,899


$

677,026

Cost of sales


161,499



170,566

Gross profit


443,400



506,460







Operating expenses:






  Selling expenses


242,699



275,965

  General and administrative expenses


148,556



167,582

Total operating expenses


391,255



443,547







Operating income


52,145



62,913

Other income (expense), net


(1,453)



1,582







Income before provision for income taxes


50,692



64,495

Provision for income taxes


11,976



17,065







Net income

$

38,716


$

47,430







Net income per share:






  Basic

$

0.77


$

0.94

  Diluted

$

0.76


$

0.91







Weighted-average common shares outstanding (000s):






  Basic


49,991



50,706

  Diluted


51,066



52,172

 

 

NU SKIN ENTERPRISES, INC.




Consolidated Balance Sheets (Unaudited)




(U.S. dollars in thousands)









March 31,
2022


December 31,
2021

ASSETS




Current assets:




  Cash and cash equivalents

$

302,216


$

339,593

  Current investments


15,313



15,221

  Accounts receivable, net


52,171



41,299

  Inventories, net


381,585



399,931

  Prepaid expenses and other


97,923



76,906

      Total current assets


849,208



872,950







Property and equipment, net


448,822



453,674

Operating lease right-of-use assets


132,949



120,973

Goodwill


206,432



206,432

Other intangible assets, net


74,874



76,991

Other assets


179,964



175,460

     Total assets

$

1,892,249


$

1,906,480







LIABILITIES AND STOCKHOLDERS' EQUITY






Current liabilities:






  Accounts payable

$

40,719


$

49,993

  Accrued expenses


343,737



372,201

  Current portion of long-term debt


110,000



107,500

      Total current liabilities


494,456



529,694







Operating lease liabilities 


100,844



88,759

Long-term debt


258,995



268,781

Other liabilities


103,754



106,474

     Total liabilities


958,049



993,708







Commitments and contingencies












Stockholders' equity:






  Class A common stock – 500 million shares authorized, $0.001 par value, 90.6
    million shares issued


91



91

  Additional paid-in capital


599,258



601,703

  Treasury stock, at cost – 40.4 million and 40.7 million shares


(1,526,778)



(1,526,860)

  Accumulated other comprehensive loss


(69,528)



(73,896)

  Retained earnings


1,931,157



1,911,734

     Total stockholders' equity


934,200



912,772

     Total liabilities and stockholders' equity

$

1,892,249


$

1,906,480

 

 




NU SKIN ENTERPRISES, INC.




Reconciliation of Earnings Per Share Excluding Impact of
Restructuring and Impairment to GAAP Earnings Per Share




(in thousands, except per share amounts)


Year Ended
2021

2022 EPS
Guidance
– low end

2022
Projected
Annual
Growth
Rate – low
end

2022 EPS
Guidance –
high end

2022
Projected
Annual
Growth
Rate – high
end







Net income

$147,266





Impact of restructuring and impairment:






   Restructuring and impairment

51,870





   Inventory write-off

6,656





   Income tax impact

6,933





Adjusted net income

$212,725





Diluted earnings per share

$2.86

$3.60

26%

$3.90

36%

 

Diluted earnings per share, excluding restructuring and impairment impact

$4.14

$3.60

(13%)

$3.90

(6%)

 

Weighted-average common shares
outstanding (000s):

51,427





 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nu-skin-enterprises-reports-first-quarter-financial-results-301539938.html

SOURCE Nu Skin Enterprises

CONTACTS: Media: media@nuskin.com, (801) 345-6397; Investors: investorrelations@nuskin.com, (801) 345-3577